{"id":24747,"date":"2022-09-19T20:17:47","date_gmt":"2022-09-20T00:17:47","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=24747"},"modified":"2023-01-24T00:46:58","modified_gmt":"2023-01-24T05:46:58","slug":"enrico-lugli-phd","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/enrico-lugli-phd","title":{"rendered":"Enrico Lugli, PhD"},"content":{"rendered":"\n<p>T cells can protect against tumor development, but can become progressively dysfunctional or \u201cexhausted\u201d as cancers progress, thus posing a major barrier to the effectiveness of immunotherapy. Recently, Dr. Lugli and his team discovered rare subpopulations of T cells in healthy individuals as well as in cancer patients that can prevent dysfunction and maintain the potential to eliminate tumors in the long term. These cells are generally referred to as \u201cstem-like\u201d T cells. Unfortunately, immune-suppressing regulatory T cells may also resist dysfunction, thus continuously allowing them to switch off anti-tumor immune responses.<\/p>\n\n\n\n<p>Having already identified stem-like T cells with precision, Lugli now seeks to utilize samples from cancer patients in combination with genomic technologies to study them in detail and reveal unprecedented aspects of their biology. Specifically, he proposes to fine-tune the molecular programs of T cells within tumors, in order to enhance the functionality of anti-tumor T cells while promoting dysfunction in the regulatory T cells on the other side. Then, he will test if these strategies can improve the effectiveness of cell therapies in preclinical models, which could pave the way for their use in humans.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">T cell stemness and exhaustion in immunosuppression and adoptive cell transfer immunotherapy<\/h3>\n\n\n\n<p>Fondazione Humanitas per la Ricerca | All Cancers | 2021<\/p>\n","protected":false},"excerpt":{"rendered":"<p>T cells can protect against tumor development, but can become progressively dysfunctional or \u201cexhausted\u201d as cancers progress, thus posing a major barrier to the effectiveness of immunotherapy. Recently, Dr. Lugli and his [&hellip;]<\/p>\n","protected":false},"featured_media":475,"template":"","tax_cancer_type":[455],"tax_grant_type":[482],"tax_award_year":[478],"tax_institutions":[640],"tax_location_states":[503],"class_list":["post-24747","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CRI Lloyd J. Old STAR","quote":"","scientist_last_name":"Lugli","show_on_landing":true,"scientist_publish_until":"20261231"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Enrico Lugli, PhD<\/title>\n<meta name=\"description\" content=\"Dr. now seeks to utilize samples from cancer patients in combination with\u00a0genomic technologies to study stem-like T cells in detail and reveal unprecedented aspects of their biology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enrico Lugli, PhD\" \/>\n<meta property=\"og:description\" content=\"Dr. now seeks to utilize samples from cancer patients in combination with\u00a0genomic technologies to study stem-like T cells in detail and reveal unprecedented aspects of their biology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-24T05:46:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1700\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd\",\"name\":\"Enrico Lugli, PhD\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg\",\"datePublished\":\"2022-09-20T00:17:47+00:00\",\"dateModified\":\"2023-01-24T05:46:58+00:00\",\"description\":\"Dr. now seeks to utilize samples from cancer patients in combination with\u00a0genomic technologies to study stem-like T cells in detail and reveal unprecedented aspects of their biology.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg\",\"width\":1700,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enrico Lugli, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enrico Lugli, PhD","description":"Dr. now seeks to utilize samples from cancer patients in combination with\u00a0genomic technologies to study stem-like T cells in detail and reveal unprecedented aspects of their biology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd","og_locale":"es_ES","og_type":"article","og_title":"Enrico Lugli, PhD","og_description":"Dr. now seeks to utilize samples from cancer patients in combination with\u00a0genomic technologies to study stem-like T cells in detail and reveal unprecedented aspects of their biology.","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd","og_site_name":"Cancer Research Institute","article_modified_time":"2023-01-24T05:46:58+00:00","og_image":[{"width":1700,"height":2560,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd","name":"Enrico Lugli, PhD","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg","datePublished":"2022-09-20T00:17:47+00:00","dateModified":"2023-01-24T05:46:58+00:00","description":"Dr. now seeks to utilize samples from cancer patients in combination with\u00a0genomic technologies to study stem-like T cells in detail and reveal unprecedented aspects of their biology.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg","width":1700,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/enrico-lugli-phd#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Enrico Lugli, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3b26e699-6a5a-4aa2-ac3a-b5ad800fd88e-scaled.jpg","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/24747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/475"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=24747"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=24747"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=24747"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=24747"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=24747"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=24747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}